Advanced Search

Oncology & Hematology Coding Alert

You Be the Coder:

Test Your Infusion Coding Mettle

Published on Thu Sep 13, 2012

Question: How should I report the following chemotherapy encounter for a patient with Ewing's sarcoma of the femur? 2mg, vincristine, IV, 5 minutes1.81 mg, dactinomycin, IV push1668 mg, cyclophosphamide, IV, 1 hour333.6 mg, mesna mixed in same bag as cyclophosphamideTexas SubscriberAnswer: Ewing's sarcoma is a rare bone cancer that is most likely to affect children and young adults. For a femur sarcoma, you should report 170.7 (Malignant neoplasm of long bones of lower limb). Remember to report V58.11 (Encounter for antineoplastic chemotherapy) first if the main purpose of the encounter is chemotherapy. The corresponding ICD-10-CM codes are C40.2- (Malignant neoplasm of long bones of ... lower limb) and Z51.11 (Encounter for antineoplastic chemotherapy). Note that the fifth character of the neoplasm code will vary based on whether the leg is unspecified (0), right (1), or left (2).For the administration, begin with the mixture of cyclophosphamide and mesna in the same bag. [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Oncology & Hematology Coding Alert

View All